Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mind Medicine (DE:MMQ)
FRANKFURT:MMQ
Holding DE:MMQ?
Track your performance easily
MMQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range€3.50 - €12.03
Previous CloseN/A
Volume187.00
Average Volume (3M)369.00
Market Cap
$488.01M
Enterprise Value€185.59M
Total Cash (Recent Filing)$80.09M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Apr 08, 2025EPS Estimate
-0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.92
Shares Outstanding73,331,690
10 Day Avg. Volume392
30 Day Avg. Volume369
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-8.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.38
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.98
Forecast
1Y Price Target
€23.71Price Target Upside235.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Mind Medicine News
PremiumCompany Announcements
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety
Options Prices
Currently, No data available
---
Ownership Overview
2.48% Insiders
5.47% Mutual Funds
0.16% Other Institutional Investors
83.33% Public Companies and Individual Investors
MMQ FAQ
What was Mind Medicine’s price range in the past 12 months?
Mind Medicine lowest stock price was €3.50 and its highest was €12.03 in the past 12 months.
What is Mind Medicine’s market cap?
Mind Medicine’s market cap is $488.01M.
When is Mind Medicine’s upcoming earnings report date?
Mind Medicine’s upcoming earnings report date is Apr 08, 2025 which is in 67 days.
How were Mind Medicine’s earnings last quarter?
Mind Medicine released its earnings results on Nov 07, 2024. The company reported -€0.173 earnings per share for the quarter, beating the consensus estimate of -€0.266 by €0.093.
Is Mind Medicine overvalued?
According to Wall Street analysts Mind Medicine’s price is currently Undervalued.
Does Mind Medicine pay dividends?
Mind Medicine does not currently pay dividends.
What is Mind Medicine’s EPS estimate?
Mind Medicine’s EPS estimate is -0.28.
How many shares outstanding does Mind Medicine have?
Mind Medicine has 73,331,690 shares outstanding.
What happened to Mind Medicine’s price movement after its last earnings report?
Mind Medicine reported an EPS of -€0.173 in its last earnings report, beating expectations of -€0.266. Following the earnings report the stock price went up 29.865%.
Which hedge fund is a major shareholder of Mind Medicine?
Currently, no hedge funds are holding shares in DE:MMQ
---
Mind Medicine Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€23.71 (235.87% Upside)
€23.71 (235.87% Upside)
Blogger Sentiment
Bullish
DE:MMQ Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $17.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
96.90%
12-Months-Change
Fundamentals
Return on Equity
-54.61%
Trailing 12-Months
Asset Growth
125.91%
Trailing 12-Months
Company Description
Mind Medicine
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
---
MMQ Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted MindMed's strong financial position and progress towards Phase III trials, while also acknowledging rising R&D expenses and a net loss. The sentiment leans towards positive due to the company's strong cash reserves and clear roadmap for advancing clinical trials.Read More>---
MMQ Stock 12 Month Forecast
Average Price Target
€23.71
▲(235.87% Upside)
Technical Analysis
Best Analysts Covering MMQ
1 Year
1 Year Success Rate
11/20 ratings generated profit
1 Year Average Return
+34.88%
reiterated a buy rating 3 months ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of +34.88% per trade.
---